A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 12, Pages 2902-2911
Publisher
Informa UK Limited
Online
2017-10-19
DOI
10.1080/21645515.2017.1356500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device
- (2015) Dinah H. Amante et al. Human Gene Therapy Methods
- DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques
- (2014) Viraj Kulkarni et al. JOURNAL OF MEDICAL PRIMATOLOGY
- Direct Transfection of Dendritic Cells in the Epidermis After Plasmid Delivery Enhanced by Surface Electroporation
- (2014) Dinah H. Amante et al. Human Gene Therapy Methods
- A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin
- (2014) Jay R McCoy et al. Human Vaccines & Immunotherapeutics
- Detection of novel divergent arenaviruses in boid snakes with inclusion body disease in The Netherlands
- (2013) R. Bodewes et al. JOURNAL OF GENERAL VIROLOGY
- Isolation, Identification, and Characterization of Novel Arenaviruses, the Etiological Agents of Boid Inclusion Body Disease
- (2013) U. Hetzel et al. JOURNAL OF VIROLOGY
- Tolerability of intramuscular and intradermal delivery by CELLECTRA®adaptive constant current electroporation device in healthy volunteers
- (2013) Malissa C Diehl et al. Human Vaccines & Immunotherapeutics
- Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
- (2013) Stephan Ölschläger et al. PLoS Pathogens
- Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole
- (2012) Dongcheng Dai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Technologies for enhanced efficacy of DNA vaccines
- (2012) Fadi Saade et al. Expert Review of Vaccines
- The search for animal models for Lassa fever vaccine development
- (2012) Igor S Lukashevich Expert Review of Vaccines
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Immune Responses and Lassa Virus Infection
- (2012) Marion Russier et al. Viruses-Basel
- Advanced Vaccine Candidates for Lassa Fever
- (2012) Igor Lukashevich Viruses-Basel
- Identification, Characterization, and In Vitro Culture of Highly Divergent Arenaviruses from Boa Constrictors and Annulated Tree Boas: Candidate Etiological Agents for Snake Inclusion Body Disease
- (2012) M. D. Stenglein et al. mBio
- Evaluation of Lassa antiviral compound ST-193 in a guinea pig model
- (2011) Kathleen A. Cashman et al. ANTIVIRAL RESEARCH
- The Multitasking Organ: Recent Insights into Skin Immune Function
- (2011) Paola Di Meglio et al. IMMUNITY
- Human Dendritic Cells Infected with the Nonpathogenic Mopeia Virus Induce Stronger T-Cell Responses than Those Infected with Lassa Virus
- (2011) D. Pannetier et al. JOURNAL OF VIROLOGY
- A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle
- (2011) Feng Lin et al. VACCINE
- Pathogenesis of lassa fever in cynomolgus macaques
- (2011) Lisa E Hensley et al. Virology Journal
- Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection
- (2011) Luis M Branco et al. Virology Journal
- T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
- (2010) Michelle Mendenhall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever
- (2010) Daniel G. Bausch et al. CLINICAL INFECTIOUS DISEASES
- Early-onset sensorineural hearing loss in Lassa fever
- (2010) T. S. Ibekwe et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs
- (2010) Xiaohong Jiang et al. VACCINE
- T Cell-Dependence of Lassa Fever Pathogenesis
- (2010) Lukas Flatz et al. PLoS Pathogens
- DNA vaccines for biodefense
- (2009) Lesley C Dupuy et al. Expert Review of Vaccines
- Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys
- (2009) S. Baize et al. JOURNAL OF VIROLOGY
- Identification of a Broad-Spectrum Arenavirus Entry Inhibitor
- (2008) R. A. Larson et al. JOURNAL OF VIROLOGY
- Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
- (2008) Brian B. Gowen et al. PLoS One
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
- Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques
- (2007) Lauren A. Hirao et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started